Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (5y) (2015 - 2021)
Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (5y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | -8.10% |
| Aug 31, 2021 | -66.89% |
| May 31, 2021 | -56.99% |
| Feb 28, 2021 | -54.61% |
| Nov 30, 2020 | -12.68% |
| Aug 31, 2020 | -13.75% |
| May 31, 2020 | -1.48% |
| Feb 29, 2020 | -41.72% |
| Nov 30, 2019 | 12.23% |
| Aug 31, 2019 | 19.07% |
| May 31, 2019 | 13.18% |
| Feb 28, 2019 | -4.44% |
| Nov 30, 2018 | -89.30% |
| Aug 31, 2018 | -11.89% |
| May 31, 2018 | -31.07% |
| Feb 28, 2018 | -8.41% |
| Nov 30, 2017 | 9.61% |
| Aug 31, 2017 | -8.08% |
| May 31, 2017 | -23.73% |
| Feb 28, 2017 | -9.82% |